Biotechnology News and Research

RSS

MGI Tech launches whole workflow solution for agricultural large-scale low-pass whole genome sequencing at PAG Asia 2024

MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, today announced a highly efficient whole workflow solution for agricultural large-scale Low-pass whole genome sequencing (Low-pass WGS) based on its proprietary DNBSEQTM platforms during this year’s International Plant and Animal Genome Conference Asia (PAG Asia 2024), taking place on June 5-7 in Shenzhen, China.

From MGI 7 Jun 2024

MGI Tech unveils new european headquarters in Berlin, Germany

MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the opening of its new European headquarters in Berlin, Germany to support the life science community across the region.

From MGI 7 Jun 2024

MGI Tech shares new data on core DNEBSEQ technology and showcases latest sequencing innovations at ESHG 2024

MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today showcased its cutting-edge technologies via a Corporate Satellite Meeting at this year’s European Society of Human Genetics (ESHG) conference in Berlin, Germany.

From MGI 7 Jun 2024

MGI Tech’s DNBSEQ-E25 and G99 platforms set record for sequencing applications at high altitude

MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, recently set a new record for sequencing applications by successfully running sample testing on its cutting-edge DNBSEQ-E25 and DNBSEQ-G99 platforms on Mount Everest.

From MGI 7 Jun 2024

InDevR and Sino Biological team up to deliver multiplexed analytical solutions for mRNA vaccine and cell & gene therapy

InDevR, Inc., a leader in analytical solutions for vaccine in-process and quality control testing, and Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext specializing in biological research reagents and related technical contract research services, today announced a new partnership to speed development of multiplexed assays for a broad range of vaccine, mRNA therapies and cell and gene therapy applications.

From Sino Biological Inc. 7 Jun 2024

Early detection and intervention as key strategies to combat colorectal cancer

Colorectal Cancer (CRC) is set to transform from a severe disease to a controllable condition through early detection and intervention.

6 Jun 2024

H.E.L Group extends sales and support with appointment of specialist distributors

H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the extension of its global sales network with the appointment of two distributors: Paralab and ProAnalytics. The new application specific distributors increase H.E.L’s sales reach and improve access to technical and field application support for biotechnology and chemical synthesis customers in Europe and the US.

From H.E.L Group 6 Jun 2024

Developing pre-symptomatic diagnostic tools for Alzheimer's disease using long-read RNA sequencing

Researchers at the University of Kentucky Sanders-Brown Center on Aging are working to develop a pre-symptomatic disease diagnostic tool for Alzheimer's disease.

6 Jun 2024

5-Cog paradigm: A breakthrough in dementia diagnosis and care

The underdiagnosis of dementia, especially among Black and Hispanic patients, is a long-standing challenge in medicine.

4 Jun 2024

Applied Cells releases game-changing reagent kits to empower cell therapy development

Applied Cells is excited to announce the launch of its MARS® Ingenuity™ Reagent kits for fast and easy cell isolation. This innovative product line features both RUO and GMP-grade reagents, and has been specifically optimized for use on Applied Cells’ proprietary MARS® Bar platform.

From Applied Cells 4 Jun 2024

Research reveals new pathways for treating never-smoker lung cancer

The primary cause of lung cancer is smoking. However, the incidence of lung cancer among never-smokers has been steadily increasing, especially among women.

4 Jun 2024

SCIEX launches new data independent acquisition, ZT Scan DIA, at ASMS 2024

At ASMS 2024, SCIEX, a global leader in life science analytical technologies, introduces ZT Scan DIA for LC-MS/MS, the next generation in data-independent acquisition (DIA) that leverages the combination of the quadrupole dimension with the rich MS2 data attainable from the Zeno trap.

From SCIEX 4 Jun 2024

Thyroid eye disease patients experience lasting improvements after treatment with teprotumumab

Most patients with thyroid eye disease treated with teprotumumab didn't require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass., and published in the journal Thyroid.

3 Jun 2024

SolasCure selected for innovate UK global incubator programme in houston

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, today announced it has been selected for Innovate UK’s Global Incubator Programme in Houston, US.

From SolasCure 3 Jun 2024

H.E.L Group extends sales and support with appointment of specialist distributors

From H.E.L Group 31 May 2024

New antibiotic lolamicin shows promise in fighting drug-resistant infections

Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut.

29 May 2024

New paper reveals the broad potential of TNIK as a therapeutic target for some aging-related diseases

A new paper in Trends in Pharmacological Sciences from researchers at generative artificial intelligence (AI)- and robotics-powered clinical stage drug discovery company Insilico Medicine ("Insilico") and ETH Zurich reveals the broad potential of TNIK as a therapeutic target for some of the most pervasive aging-related diseases, including fibrosis, cancer, obesity, and Alzheimer's.

28 May 2024

Exonate appoints Dr Rafiq Hasan as Non-Executive Director

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced the expansion of its Board with the appointment of Dr Rafiq Hasan as Non-Executive Director. Rafiq brings extensive expertise in ophthalmology, specifically within the diabetic eye disease sector, from his years in global pharmaceutical businesses.

28 May 2024

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention

Leadership from clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine ("Insilico") will attend the BIO International Convention in San Diego June 3-6 and present on key issues facing AI drug discovery.

23 May 2024

Breakthrough study reveals molecular drivers of Alzheimer's progression

According to the US Centers for Disease Control and Prevention, at least 5.8 million Americans are currently living with Alzheimer's disease, which is the most common form of dementia.

23 May 2024

Biotechnology News and Research

MGI Tech launches whole workflow solution for agricultural large-scale low-pass whole genome sequencing at PAG Asia 2024

MGI Tech unveils new european headquarters in Berlin, Germany

MGI Tech shares new data on core DNEBSEQ technology and showcases latest sequencing innovations at ESHG 2024

MGI Tech’s DNBSEQ-E25 and G99 platforms set record for sequencing applications at high altitude

InDevR and Sino Biological team up to deliver multiplexed analytical solutions for mRNA vaccine and cell & gene therapy

Early detection and intervention as key strategies to combat colorectal cancer

H.E.L Group extends sales and support with appointment of specialist distributors

Developing pre-symptomatic diagnostic tools for Alzheimer's disease using long-read RNA sequencing

5-Cog paradigm: A breakthrough in dementia diagnosis and care

Applied Cells releases game-changing reagent kits to empower cell therapy development

Research reveals new pathways for treating never-smoker lung cancer

SCIEX launches new data independent acquisition, ZT Scan DIA, at ASMS 2024

Thyroid eye disease patients experience lasting improvements after treatment with teprotumumab

SolasCure selected for innovate UK global incubator programme in houston

H.E.L Group extends sales and support with appointment of specialist distributors

New antibiotic lolamicin shows promise in fighting drug-resistant infections

New paper reveals the broad potential of TNIK as a therapeutic target for some aging-related diseases

Exonate appoints Dr Rafiq Hasan as Non-Executive Director

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention

Breakthrough study reveals molecular drivers of Alzheimer's progression

Biotechnology eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News